Kurs Cepheid

Aktien

15.02.17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV
05.11.16	Cepheid : Danaher Completes Acquisition Of Cepheid
27.10.16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US
24.10.16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation
05.10.16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring

Manager	Titel	Alter	Seit
Charles Mwangi DFI	Finanzdirektor/CFO	59	01.07.2023
Anupama Mokkapati COO	Geschäftsführer	-	01.11.2021
Laurent Bellon COO	Geschäftsführer	-	01.08.2018

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
CEPHEID	-.--%	+0.36%	-	-	0
THERMO FISHER SCIENTIFIC, INC.	+3.19%	+6.47%	+31.50%	+42.09%	249 Mrd.
DANAHER CORPORATION	+3.22%	+6.69%	+12.57%	+10.24%	158 Mrd.
INTUITIVE SURGICAL, INC.	+1.77%	+2.66%	-2.10%	+55.55%	148 Mrd.
BOSTON SCIENTIFIC CORPORATION	+2.22%	+4.19%	-55.17%	-12.57%	62.32 Mrd.
SIEMENS HEALTHINEERS AG	+1.95%	+6.77%	-13.31%	-14.31%	49.61 Mrd.
EDWARDS LIFESCIENCES CORPORATION	+0.27%	+2.73%	+18.66%	+21.43%	49.83 Mrd.
VEEVA SYSTEMS INC.	+4.81%	+9.36%	+8.39%	+46.96%	48.14 Mrd.
AGILENT TECHNOLOGIES, INC.	+1.27%	+4.78%	+26.18%	+58.04%	49.06 Mrd.
WATERS CORPORATION	+1.95%	+3.76%	+33.95%	+74.49%	42.9 Mrd.
Durchschnitt	+2.03%	+2.20%	+6.74%	+31.32%	95.24 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	+2.54%	+1.95%	+11.07%	+32.92%